ULTA BEAUTY INC
ULTANASDAQ🏆 #465 by market capEarnings Aug 27US Equity
$541.35▼ $7.20 (−1.33%)
🌅 Pre-market$541.35▲ 0.00%Regular close · extended-hours price shown1h—
24h▼ 1.3%
7d▲ 0.3%
14d▲ 6.6%
30d▲ 14.4%
1y▲ 4.9%
🏦Market Cap
$23.27B
Mid Cap
📈Revenue Growth (YoY)
+9.7%
Slowing
📊Gross Margin
39.3%
Healthy
💵FCF Margin
8.3%
Moderate
⚖️P/S Ratio
1.8x
Cheap
Otter Score
56
Weak
📊
Analyst Ratings
Price
$541.35
Total
47
Raised
3
Lowered
6
Avg PT
$645.00
H / L
$735 / $550
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-06-09 |
Citigroup | Reiterated | Neutral | 2026-06-04 |
B. Riley Securities | Reiterated | Neutral | 2026-06-03 |
Morgan Stanley | Reiterated | Overweight | 2026-06-03 |
Canaccord Genuity | Reiterated | Buy | 2026-06-03 |
DA Davidson | Reiterated | Buy | 2026-06-03 |
Piper Sandler | Reiterated | Overweight | 2026-06-03 |
Wells Fargo | Reiterated | Underweight | 2026-06-03 |
Evercore ISI Group | Reiterated | Outperform | 2026-06-03 |
JP Morgan | Reiterated | Overweight | 2026-06-03 |
Baird | Reiterated | Outperform | 2026-06-03 |
Barclays | Reiterated | Overweight | 2026-06-03 |
UBS | Reiterated | Buy | 2026-06-03 |
Goldman Sachs | Reiterated | Buy | 2026-06-03 |
Jefferies | Upgraded | Hold → Buy | 2026-04-20 |
Telsey Advisory Group | Reiterated | Outperform | 2026-03-13 |
Oppenheimer | Reiterated | Outperform | 2026-03-13 |
Raymond James | Upgraded | Outperform → Strong Buy | 2026-01-21 |
B of A Securities | Reiterated | Neutral | 2026-01-08 |
Argus Research | Reiterated | Buy | 2026-01-02 |
Guggenheim | Reiterated | Neutral | 2025-12-05 |
Loop Capital | Downgraded | Buy → Hold | 2025-07-25 |
Truist Securities | Reiterated | Neutral | 2025-05-15 |
BMO Capital | Reiterated | Market Perform | 2025-03-14 |
Stifel | Reiterated | Hold | 2025-03-14 |
William Blair | Downgraded | Outperform → Market Perform | 2024-11-21 |
Deutsche Bank | Reiterated | Buy | 2024-10-09 |
Cleveland Research | Downgraded | Buy → Neutral | 2024-08-19 |
Credit Suisse | Reiterated | Outperform | 2023-03-10 |
Cowen & Co. | Reiterated | Outperform | 2023-02-16 |
CFRA | Reiterated | Buy | 2020-05-29 |
Nomura Instinet | Reiterated | Neutral | 2020-05-11 |
Nomura | Reiterated | Neutral | 2020-05-11 |
PiperJaffray | Reiterated | Neutral | 2019-12-02 |
Piper Jaffray | Downgraded | Overweight → Neutral | 2019-08-30 |
Atlantic Equities | Downgraded | Overweight → Neutral | 2019-08-30 |
OTR Global | Downgraded | Positive → Mixed | 2019-08-23 |
Argus | Reiterated | Buy | 2018-10-17 |
Stifel Nicolaus | Reiterated | Hold | 2018-08-31 |
Buckingham Research | Reiterated | Buy | 2018-05-30 |
Buckingham | Reiterated | Buy | 2018-05-30 |
KeyBanc | Reiterated | Overweight | 2018-03-16 |
Keybanc | Reiterated | Overweight | 2018-03-15 |
BB&T Capital | Reiterated | Hold | 2016-04-20 |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2016-02-26 |
RBC Capital | Reiterated | Sector Perform → Perform | 2015-09-10 |
Sterne Agee | Reiterated | Buy | 2013-06-18 |
One row per institution, most recent rating